Prostate cancer drug shows promise in new clinical trial

In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity ...

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the third quarter ended September 30, 2026.
Independent Newspaper Nigeria

Nigeria Breaks New Ground As Imo Establishes Africa’s First Robotic Surgery Academy

Partnership Moves To Train 500 Professionals, Bring Advanced Surgery Closer To Citizens  Lagos - Africa’s first dedicated ...

Micropos Medical: Cooperation for greater awareness of high precision radiotherapy for prostate cancer

Modern radiotherapy for prostate cancer is as effective as surgery with important advantages in preservation of urinary ...

Gisborne’s Mātai treats first patient with MRI-guided prostate cancer ablation

Gisborne’s Mātai Medical Research Institute has treated its first patient using a new and minimally invasive MRI-guided transurethral ultrasound ablation service. On Saturday, Mātai opened the Hugh ...